| Abstract |
India’s initiative at providing structured antiretroviral therapy (ART) has raised hope among people living with HIV/AIDS. However, provision of ART has significant financial implications. This study attempts to estimate the unit cost of providing first-line ART in India and using this estimate ascertain the financial requirements of a public funded ART programme in India over a period of five years under two different scenarios. |